key: cord-0954338-u2m028oz
authors: Llinás-Caballero, Kevin; Rodríguez, Yhojan; Fernández-Sarmiento, Jaime; Rodríguez-Jiménez, Mónica; Anaya, Juan-Manuel
title: Kawasaki disease in Colombia: a systematic review and contrast with multisystem inflammatory syndrome in children associated with COVID-19
date: 2021-01-28
journal: nan
DOI: 10.1016/j.rcreu.2020.11.004
sha: 175cd4283635b2905c2f1c527f69d314661b4660
doc_id: 954338
cord_uid: u2m028oz

Background: Kawasaki disease (KD) is an acute vasculitis with multisystem involvement. Recently, the increasing incidence of a condition that closely resembles KD in many cases, named multisystem inflammatory syndrome in children (MIS-C), has set off alarms amid the current worldwide coronavirus disease-19 (COVID-19) pandemic. Hence, the aim is to conduct a systematic review of the literature about KD in Colombia and contrast it with COVID-19-related MIS-C. Materials and methods: A search was carried out in both international and Latin American electronic databases for publications concerning patients with KD in the Colombian population. Records were then screened by titles and/or abstracts, assessed for eligibility, and reviewed. Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines were followed. The search included studies reporting MIS-C associated with COVID-19, and compared these patients with our findings of KD in Colombia. Results: Out of 36 publications retrieved, 17 were included, representing 120 individuals. Male to female ratio was 1.6, and most patients (90.4%) were aged 5 years or less. Among the main features of KD, fever was the most frequent (96.2% of the patients), while cervical lymphadenopathy was present in only 40.6%. Intravenous immunoglobulin was administered in 91.4% cases and 6.2% were resistant. Cardiac involvement was found in around 30%, and 20% had coronary artery lesions. Comparison between MIS-C associated with COVID-19 and KD in Colombia indicates that patients affected by MIS-C were older (72.2% of MIS-C patients > 5 years), had higher rates of cardiac involvement, and required critical care more often. Conclusions: Our findings of KD in Colombia are consistent with the available descriptions of KD in the scientific literature. Given the increasing rate of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in Colombia and Latin America, our study raises awareness about MIS-C in paediatric patients with COVID-19 and its relationship with KD.

Kawasaki disease (KD) is an acute, self-limited, systemic vasculitis, which primarily involves small and medium-sized vessels. 1 It affects mostly males between 6 months and 5 years old, being the most common medium-sized-vessel vasculitis. 2, 3 Several theories have been proposed regarding the etiology of this condition, including pathogens, toxins, and autoimmune or autoinflammatory processes. 4, 5 Even though the current evidence points towards an infectious agent accompanied by a dysregulated immune response, a univocal agreement about the exact cause or causes of KD is lacking so far. 2 Therefore, KD is nowadays considered to be a vasculitis of unknown origin, with a predilection for coronary arteries. 6 Although acute manifestations usually resolve promptly upon adequate treatment, long-term cardiovascular sequelae, mainly coronary artery lesions (CALs), may develop in some patients. In fact, KD is the leading cause of acquired Page 6 of 37 J o u r n a l P r e -p r o o f 6 heart disease among children in developed countries. 7 Nonetheless, if KD is identified and treated early, the risk of coronary artery aneurysms (CAAs) declines from 25% to 4%. 8 In 1967, six years after seeing the first child presenting with a particular constellation of clinical manifestations, Japanese pediatrician Tomisaku Kawasaki described 50 patients that experienced an 'acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes'. 9, 10 Subsequently, this syndrome was named mucocutaneous lymph node syndrome, and cases were reported outside Japan. 11,12 Some years after that, KD was defined as equivalent to infantile periarteritis nodosa. 13 Currently, the coronavirus-19 disease (COVID- 19) , caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus, has become a global public health issue. Interestingly, a link between SARS-CoV-2 infection and KD has been suggested following an increase of cases of KD, Kawasaki-like disease, and other inflammatory syndromes in multiple countries struck by the COVID-19. [14] [15] [16] [17] [18] This condition has been termed multisystem inflammatory syndrome in children (MIS-C) temporally associated with COVID-19, among other names, and has posed several questions about the nature and the implications of this relationship. 19 Since KD is considered not a very frequent condition, and the COVID-19 pandemic has been associated with MIS-C, we aimed to review the status of KD in Colombia and contrast the results with the clinical characteristics of MIS-C linked to COVID-19 in order to raise awareness of this association. 7 

A systematic review of the literature was done up to July 18 th , 2020. The search was performed both in international and Latin American electronic databases. For this purpose, we searched using the terms: («Kawasaki disease» OR «Kawasaki's disease" OR «Kawasaki syndrome" OR «Kawasaki's syndrome» OR «Kawasaki vasculitis» OR «Kawasaki's vasculitis» OR «mucocutaneous lymph node syndrome») AND «Colombia», or their Spanish language counterparts, in PubMed, LILACS, Embase and Web of Science. A more stringent search approach was also done in LILACS but yielded the same results (see Additional file 1). To identify potential additional studies for inclusion, we also hand-searched through other sources, including grey literature, and manually looked up the references of the articles found by the search strategy initially described above. No date, language, or population limits were applied.

Articles included had to have been conducted in Colombian population and to describe methods implemented to study, diagnose, treat, or rehabilitate patients suffering from KD at any age. In addition to this, studies reporting the clinical outcomes of patients with KD were also eligible. Case reports, case series, crosssectional, case-control, cohort (either prospective or retrospective), or clinical trial studies were suitable for inclusion. Studies that were not carried in the population of interest, or that did not present relevant outcomes for the population of interest Page 8 of 37 J o u r n a l P r e -p r o o f 8 separately to those for other populations were excluded. We also ruled out records whose full text was not available to us, as well as systematic or narrative reviews and meta-analyses.

First, a primary reviewer screened all titles and/or abstracts of the publications found. Following this, eligibility assessment was performed. Retrieved articles were rejected if eligibility criteria were not met, and two secondary reviewers were consulted in cases in which eligibility criteria were unclear. After this, a single researcher collected the information regarding population, study design, clinical characteristics, treatment, and outcomes of all included studies; thereafter, a second reviewer verified the extracted information. Any discrepancies or missing information were resolved by consensus.

Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines were followed. 20

In order to find articles reporting cases of MIS-C related to COVID-19, we searched on PubMed on July 18 th , 2020 using the following search string: (SARS-CoV-2 OR COVID-19) AND (multisystem inflammatory syndrome in children OR MIS-C OR pediatric multisystem inflammatory syndrome OR PIMS) and selected the articles corresponding to MIS-C related to COVID-19. No date, language, or population limits were applied. Some references found through hand-searching were also J o u r n a l P r e -p r o o f 9 included. We then contrasted our results of KD in Colombia with the information on these studies. Statistical analysis was performed using 2 test and p-value < 0,05 was considered significant.

A total of ten articles were identified through database searching, and 29 additional records from other resources were found. After duplicates removal, the titles and/or abstracts of 36 articles were screened. In the screening phase, ten articles were excluded. Twenty-six full-text articles were assessed for eligibility.

A study by Momenah et al. 21 was excluded because it was not about Colombian population. Likewise, eight articles whose titles contained the search terms were also excluded because it was not possible to find out the full texts.

Ultimately, 17 publications were included in the qualitative synthesis for analysis ( Figure 1 ). Table 1 summarizes the main features of these studies. [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] 

In the included studies, a total of 120 Colombian patients affected by KD were reported. 74 were males, with a male to female ratio of 1.6:1. Almost all of our patients (99.2%) were children or adolescents (< 18 years). Among the 73 patients whose exact age was reported, 66 were ≤ 5 years. A single case was reported in an adult male aged 36 years.

From the reported cases, information about clinical presentation was available for 106 of them. The studies included were reviewed in the light of the American Heart Association (AHA) 8 and the Japanese Circulation Society (JCS) criteria. 39 All patients met at least one of these criteria sets for either complete or incomplete KD. Data regarding AHA and JCS criteria fulfillment are presented in Table 2 .

Concerning the principal symptoms of KD in these 106 patients, 102 of them presented with prolonged fever, 67 to 69 had peripheral extremity involvement (i.e., 

Out of the 120 patients, the therapeutic approach was described for 116 of them.

Among those, intravenous immunoglobulin (IVIG) was administered to 106 usually at doses of 2 g/kg, while 91 received acetylsalicylic acid (ASA). Eighteen patients 

Cardiac involvement was evidenced either clinically, by electrocardiography, or by cardiac imaging, in 36 to 38 patients. At least 48 individuals had an echocardiogram performed, and 21 or more showed abnormal results. Valvular heart disease was evidenced in 9 cases (regurgitation in all of them). Pericardial effusion or pericarditis was observed in 8 cases as well. Ejection fraction was J o u r n a l P r e -p r o o f 12 reported as 25% in one patient, and below 70% in 2. Importantly, one had a previous history of a restrictive interventricular communication but also showed pericardial effusion in an echocardiogram performed during the workup. Two follow-up echocardiograms of this patient were reported as normal. CALs, including CAAs, were diagnosed in 24 cases. Ten patients had evidence of CAAs. No deaths were reported in the reviewed articles.

We collected 45 articles respecting MIS-C linked to COVID-19 and compared the patients reported there with those included in our review of KD in Colombia. Of note, all the latter were diagnosed with KD before the COVID-19 epidemic. MIS-C group comprehended 961 patients, three of them being adults (0.3%). Taking into account that the cases of KD in Colombia also included an adult cases, these three adult cases were not excluded. Information about age, sex, presence of main symptoms of KD, evidence of SARS-CoV-2 infection, ICU requirement, use of IVIG and ASA, cardiac involvement, and mortality for both groups is shown in Table 3 . [14] [15] [16] [17] [18] Discussion KD occurs mainly in children and adolescents, and 85% of the patients are ≤ 5 years old. 80 Therefore, the diagnosis of KD in adults is exceedingly rare, and very few cases have been reported worldwide. 30 Furthermore, this condition is more frequent among male individuals, with a male to female ratio around 1.5 to 1 2 .

Page 13 of 37 J o u r n a l P r e -p r o o f 13 Consistent with these data, in the patients included in this study, 90.4% were aged 5 years or less, and most of them were male, with a male to female ratio of 1.6 to 1. However, in the articles reviewed, a case of a 36-years-old adult diagnosed with KD was reported. 30 There are two main sets of diagnostic criteria used for KD, proposed by the AHA and the JCS separately. 8, 39 Despite being very similar to each other, the main difference between them is the fever being or not a requisite for the diagnosis.

According to our analysis, the fulfillment of AHA and JCS criteria is very similar through the cases reported (Table 2 ).

In the AHA criteria, persistent fever (usually persisting ≥ 5 days) is a sine qua non characteristic for the diagnosis of complete (or classic) KD and must be accompanied by at least four out of five main clinical findings. 8 Conversely, the JCS criteria consider fever as one of six principal symptoms, and diagnosis is made when at least 5 of them are present. 39 Differential diagnosis is key in KD,

given that other illnesses must be ruled out to reach a correct diagnosis of KD.

Besides fever, changes of the oral cavity and lips are the commonest clinical feature in KD (96.5%), followed by polymorphous rash (96%), non-purulent bilateral conjunctivitis (89%), changes in the extremities (75.6%), and cervical lymphadenopathy (62.7%). 81 In our patients, fever was present in 96.2% of them, while cervical lymphadenopathy was the least frequent of the main symptoms, found in 40.6% of the cases.

Moreover, some patients that do not meet criteria to diagnose complete KD are thus evaluated for incomplete KD. AHA guidelines include an algorithm for the J o u r n a l P r e -p r o o f 14 management of these patients according to C reactive protein values, other laboratory findings, and echocardiogram results. 8 Table 2 shows how many patients were classified as incomplete KD according to each set of criteria. Special attention should be paid to the incomplete forms of the disease, which may be observed early during the course of the illness (i.e., the first days), as well as the forme frustre of this syndrome. 28, 31, 34, 35 The mainstay of the treatment for KD consists of IVIG (2 g/kg) within 10 days of the onset of symptoms, and ASA. 4 The administration of IVIG must be done slowly, and premedication with antihistamines is often encouraged 4 infection. Accordant with available descriptions, 85 we found that 72.2% of MIS-C cases were in children older than 5 years, which is substantially different than our KD in Colombia findings. Furthermore, while KD has been associated with East Asian origin, MIS-C tends to affect more children of African American, Caribbean and Hispanic ancestry. 85 This is of special interest to us given the triethnic origin of J o u r n a l P r e -p r o o f 16 our population; withal, lack of consistency in reporting ethnic origin or ancestry among Colombian KD cases precluded further comparisons.

As previously described, 85 the proportions of principal clinical findings of KD were lower in MIS-C patients compared to those included in our review, with statistically significant differences (except for fever). Correspondingly, as opposed to Colombian patients, IVIG was used less in the MIS-C group. These findings can be explained by the fact that not all the patients diagnosed with MIS-C had a presentation leading to KD diagnosis.

Besides traditionally measured acute phase reactants such as CRP and ESR, serum ferritin is very often elevated in MIS-C patients. 84 Ferritin is a significant marker of M1 macrophage activation. 86 Thus, it plays a key role in the workup of patients with suspected MIS-C. 87 Nonetheless, we were not able to compare ferritin levels and other inflammatory parameters between global MIS-C versus Colombian KD patients because those variables are not systematically assessed in KD and were not included in Colombian reports.

Interestingly, we found a much greater rate of cardiac involvement in MIS-C patients than that found by us in Colombian KD patients. Likewise, more MIS-C patients required ICU management because of shock or other severe presentations. These results are consistent with the existing literature about this syndrome. 19, 88 Despite mortality being higher in the MIS-C group (1.8%), this difference was not statistically significant.

Nevertheless, some limitations should be noted. First, we collected a limited sample of patients, which may be in part due to the relative infrequency and/or underdiagnosis of the condition studied; but it is also because we could not retrieve the full text of all the articles reporting KD cases in Colombian population. The heterogeneous reporting of clinical characteristics and other attributes, along with the changing definition of MIS-C, may have hindered our analyses. We could not fully exclude a potential overlap within both groups. It is of note that we did not intend to perform a systematic review or a detailed description of the MIS-C cases here included, but to make a comparison between this cases and Colombian KD cases ascertained through a systematic review.

KD is an idiopathic medium-sized-vessel vasculitis with multisystemic involvement that causes damage predominantly in extraparenchymal arteries, mostly coronary arteries. This syndrome is almost exclusive of pediatric patients but can seldom be found in adults. Even though the diagnosis is challenging, the timely administration of adequate treatment is a game-changer in the long-term outcomes of the disease. In this study, we found that KD Colombian patients exhibit similar characteristics with the international literature.

On the other hand, the rather recent outbreak of COVID-19 all over the world has brought forward several problems, including an association with an increase of cases of MIS-C, many of them presenting with features consistent with KD. This syndrome linked to COVID-19 seems to affect older children more, have higher rates of cardiac involvement, and entail more severe presentations requiring 

Not applicable.

Not applicable.

Data generated or analysed during this study are included in this published article (and its supplementary information files). Further datasets are available from the corresponding author on reasonable request.

The authors declare that they have no competing interests. 

Kawasaki disease: Current aspects on aetiopathogenesis and therapeutic management

Dissecting Kawasaki disease: a state-of-the-art review

Is Kawasaki disease an infectious disorder?

Kawasaki disease

How Should we classify Kawasaki disease? Front Immunol

Kawasaki disease: Pathophysiology, clinical manifestations, and management

Kawasaki disease: Insights into pathogenesis and approaches to treatment

Diagnosis, treatment, and long-term management of kawasaki disease: a scientific statement for health professionals from the American Heart

Are infantile periarteritis nodosa with coronary artery involvement and fatal mucocutaneous lymph node syndrome the same? Comparison of 20 patients from North America with patients from Hawaii and Japan

An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study

Hyperinflammatory shock in children during COVID-19 pandemic

Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic

Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic

Pediatric inflammatory syndrome temporally related to covid-19

Preferred reporting Items for systematic reviews and meta-analyses: The PRISMA statement

Kawasaki disease in the older child

Hallazgos imagenológicos en la perfusión miocárdica con isonitrilos con SPECT en pacientes con diagnóstico de enfermedad de Kawasaki en las Clínicas Colsanitas de Bogotá

Report of a rare case in an adult

Enfermead de Kawasaki incompleta en un adolescente. Informe de un caso

Enfermedad de Kawasaki, reporte de casos

Rev Colomb Cardiol

Enfermedad de Kawasaki incompleta

Enfermedad de Kawasaki: dificultades en el diagnóstico y tratamiento. Presentación de dos casos

Enfermedad de Kawasaki: serie de casos clínicos enero 2006 -febrero del 2009 en Bogotá

Guidelines for diagnosis and management of cardiovascular sequelae in kawasaki disease (JCS 2013) -Digest version

Neurologic and radiographic findings associated with COVID-19 infection in children

Hyperinflammatory shock related to COVID-19 in a patient presenting with multisystem inflammatory syndrome in children: First case from Iran

Special dermatological presentation of paediatric multisystem inflammatory syndrome related to COVID-19: erythema multiforme

SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study

Bilateral anterior uveitis as a part of a multisystem inflammatory syndrome secondary to COVID-19 Med Virol

Cardiac MRI of children with multisystem inflammatory syndrome (MIS-C) associated with COVID-19: case series

Oral ulceration as presenting feature of paediatric inflammatory multisystem syndrome associated with COVID-19

Characteristics, cardiac involvement, and outcomes of multisystem inflammatory disease of childhood (MIS-C) associated with SARS-CoV-2 Infection

Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York City

Multisystem inflammatory syndrome in children during the Coronavirus 2019 pandemic: a case series

Septic shock Page 28 of 37 with COVID-19

A Case of pediatric multisystem inflammatory syndrome temporally associated with COVID-19 in South Dakota

Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study

Clinical manifestations and outcomes of critically Ill children and adolescents with COVID-19 in New York City

COVID-19-associated pediatric multisystem inflammatory syndrome

Pediatric Crohn's disease and multisystem inflammatory syndrome in children (MIS-C) and COVID-19 treated with infliximab

Multisystem inflammatory syndrome in children in New York State

Toxic shock-like syndrome and COVID-19: A case report of multisystem inflammatory syndrome in children (MIS-C)

Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children

Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in Children (MIS-C)

Spectrum of imaging findings on chest radiographs, US, CT, and MRI images in multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19

COVID-19 and Kawasaki disease: novel virus and novel case

Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome Coronavirus 2 infection: a multi-institutional study from New York City

SARS-CoV-2-induced Kawasaki-like hyperinflammatory syndrome: a novel covid phenotype in children

Gastrointestinal symptoms as a major presentation component of a novel multisystem inflammatory syndrome in children (MIS-C) that is related to COVID-19: a single center experience of 44 cases

Multisystem inflammatory syndrome in three teenagers with confirmed SARS-CoV-2 infection

Serology confirms SARS-CoV-2 infection in PCR-negative children presenting with paediatric inflammatory multi-system syndrome

Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort

Paediatric inflammatory multisystem syndrome: temporally associated with SARS-CoV-2 (PIMS-TS): cardiac features, management and short-term outcomes at a UK tertiary paediatric hospital

Multisystem inflammatory syndrome with features of atypical Kawasaki disease during COVID-19 Pandemic

Pediatric inflammatory multisystem syndrome with central nervous system involvement and hypocomplementemia following sars-cov-2 Infection

Multisystem inflammatory syndrome in children (MIS-C) related to COVID-19: A New York City experience

Incomplete Kawasaki Page 32 of 37 with Covid-19. Indian Pediatr

New onset severe right ventricular failure associated with COVID-19 in a young infant without previous heart disease

Neurological manifestations of pediatric multi-system inflammatory syndrome potentially associated with COVID-19. Child's Nerv Syst

An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19

Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company †TM s public news and information

Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19 . The COVID-19 resource centre is hosted on Elsevier Connect , the company †TM s public news and information

Clinical characteristics of 58 Children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2

Dermatological manifestation of pediatrics multisystem inflammatory syndrome associated with COVID -19 in a 3-year-old girl

Kawasaki syndrome

Diagnosis and management of kawasaki disease

Presentation and outcomes of Kawasaki disease in Latin American infants younger than 6 months of age: a multinational multicenter study of the REKAMLATINA Network

system inflammatory syndrome in children (MIS-C) following SARS-CoV-2 infection: review of clinical presentation, hypothetical pathogenesis, and proposed management

SARS-CoV-2-Related inflammatory multisystem syndrome in children

Differential regulation of iron homeostasis during human macrophage polarized activation

typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin

Multisystem inflammatory syndrome in children (MIS-C) with COVID-19: insights from simultaneous familial Kawasaki Disease cases

Multidisciplinary guidance regarding the use of immunomodulatory therapies for acute COVID-19 in pediatric patients

Autoinflammatory and autoimmune conditions at the crossroad of COVID-19

Figure 1-Selection process. We followed the PRISMA guidelines for reporting in systematic reviews and meta-analyses